Ranbaxy expanding India plant; Aesica researches new API-making methods;

> The expansion of a Ranbaxy Laboratories plant in Mohali, India, is slated to begin in 2014, the company says. Story

> Catalent has signed a development and manufacturing deal with UMN Pharma in Japan to produce biosimilar cell lines. Item

> Aesica Pharmaceuticals is partnering with Durham and Leeds universities in the U.K. to develop new or improved routes for the manufacture of APIs. Release

> Gerresheimer, the German manufacturer of glass and plastic packaging for the pharmaceutical industry, is buying a majority interest in Triveni, an Indian packaging manufacturer. Item

> U.K. tooling company iHolland is working on technology to help drugmakers predict which nonstick coating is best for certain tablet manufacturing. Story

And finally... The FDA has approved a new new four-strain seasonal flu vaccine from GlaxoSmithKline ($GSK), which the company will have in production for the 2013-2014 flu season. Story